Publicacións (21) Publicacións de VALENTINA SATTA

2023

  1. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

    Neuropharmacology, Vol. 237

  2. Endocannabinoid-Binding Receptors as Drug Targets

    Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94

  3. Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Editorial: Cannabinoids as potential treatment for neurological diseases

    Frontiers in Neuroscience

  2. Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome

    Neuropharmacology, Vol. 205

2021

  1. Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments

    Frontiers in Molecular Neuroscience, Vol. 13

2020

  1. Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

2019

  1. Animal models of eating disorders

    Methods in Molecular Biology (Humana Press Inc.), pp. 297-314

  2. Brain activity of anandamide: a rewarding bliss?

    Acta Pharmacologica Sinica, Vol. 40, Núm. 3, pp. 309-323

  3. Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa

    International Journal of Eating Disorders, Vol. 52, Núm. 11, pp. 1251-1262

2018

  1. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

    Biochemical Pharmacology, Vol. 157, pp. 85-96

  2. Limited access to a high fat diet alters endocannabinoid tone in female rats

    Frontiers in Neuroscience, Vol. 12, Núm. FEB

  3. Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists

    Bioorganic and Medicinal Chemistry, Vol. 26, Núm. 1, pp. 295-307

2017

  1. Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia

    British Journal of Pharmacology, Vol. 174, Núm. 16, pp. 2682-2695

2016

  1. Adolescent Δ 9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats

    Neuropsychopharmacology, Vol. 41, Núm. 5, pp. 1416-1426

  2. Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome

    Pharmacology Research and Perspectives, Vol. 4, Núm. 2

  3. Emotional profile of female rats showing binge eating behavior

    Physiology and Behavior, Vol. 163, pp. 136-143

2015

  1. The endocannabinoid system: Anorexia nervosa and binge eating disorder

    Cannabinoids in Neurologic and Mental Disease (Elsevier Inc.), pp. 389-413

2013

  1. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats

    British Journal of Pharmacology, Vol. 169, Núm. 4, pp. 820-833

2012

  1. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: Role of CB1 and CB2 receptors

    ACS Chemical Neuroscience